Varicella zoster meningitis following COVID-19 vaccination: a report of two cases

Most of the adverse effects reported in patients who have received COVID-19 vaccines have been mild. However, possible serious adverse effects are being monitored cautiously. There have also been a number of case reports of reactivation of varicella zoster infection within 28 days after immunization...

Descripción completa

Detalles Bibliográficos
Autores principales: Buranasakda, Marturod, Kotruchin, Praew, Phanthachai, Kittisap, Mootsikapun, Piroon, Chetchotisakd, Ploenchan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964532/
https://www.ncbi.nlm.nih.gov/pubmed/35367355
http://dx.doi.org/10.1016/j.ijid.2022.03.055
_version_ 1784678241753104384
author Buranasakda, Marturod
Kotruchin, Praew
Phanthachai, Kittisap
Mootsikapun, Piroon
Chetchotisakd, Ploenchan
author_facet Buranasakda, Marturod
Kotruchin, Praew
Phanthachai, Kittisap
Mootsikapun, Piroon
Chetchotisakd, Ploenchan
author_sort Buranasakda, Marturod
collection PubMed
description Most of the adverse effects reported in patients who have received COVID-19 vaccines have been mild. However, possible serious adverse effects are being monitored cautiously. There have also been a number of case reports of reactivation of varicella zoster infection within 28 days after immunization with mRNA COVID-19 vaccines. A few cases have also been reported after viral vector and inactivated COVID-19 vaccination. The incidence of meningitis following varicella zoster virus infection is rare. In the current study, we report two cases of male patients who received two different types of COVID-19 vaccine (inactivated and viral vector) and developed varicella zoster meningitis within 10 days after vaccination.
format Online
Article
Text
id pubmed-8964532
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
record_format MEDLINE/PubMed
spelling pubmed-89645322022-03-30 Varicella zoster meningitis following COVID-19 vaccination: a report of two cases Buranasakda, Marturod Kotruchin, Praew Phanthachai, Kittisap Mootsikapun, Piroon Chetchotisakd, Ploenchan Int J Infect Dis Case Report Most of the adverse effects reported in patients who have received COVID-19 vaccines have been mild. However, possible serious adverse effects are being monitored cautiously. There have also been a number of case reports of reactivation of varicella zoster infection within 28 days after immunization with mRNA COVID-19 vaccines. A few cases have also been reported after viral vector and inactivated COVID-19 vaccination. The incidence of meningitis following varicella zoster virus infection is rare. In the current study, we report two cases of male patients who received two different types of COVID-19 vaccine (inactivated and viral vector) and developed varicella zoster meningitis within 10 days after vaccination. The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022-06 2022-03-30 /pmc/articles/PMC8964532/ /pubmed/35367355 http://dx.doi.org/10.1016/j.ijid.2022.03.055 Text en © 2022 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Case Report
Buranasakda, Marturod
Kotruchin, Praew
Phanthachai, Kittisap
Mootsikapun, Piroon
Chetchotisakd, Ploenchan
Varicella zoster meningitis following COVID-19 vaccination: a report of two cases
title Varicella zoster meningitis following COVID-19 vaccination: a report of two cases
title_full Varicella zoster meningitis following COVID-19 vaccination: a report of two cases
title_fullStr Varicella zoster meningitis following COVID-19 vaccination: a report of two cases
title_full_unstemmed Varicella zoster meningitis following COVID-19 vaccination: a report of two cases
title_short Varicella zoster meningitis following COVID-19 vaccination: a report of two cases
title_sort varicella zoster meningitis following covid-19 vaccination: a report of two cases
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964532/
https://www.ncbi.nlm.nih.gov/pubmed/35367355
http://dx.doi.org/10.1016/j.ijid.2022.03.055
work_keys_str_mv AT buranasakdamarturod varicellazostermeningitisfollowingcovid19vaccinationareportoftwocases
AT kotruchinpraew varicellazostermeningitisfollowingcovid19vaccinationareportoftwocases
AT phanthachaikittisap varicellazostermeningitisfollowingcovid19vaccinationareportoftwocases
AT mootsikapunpiroon varicellazostermeningitisfollowingcovid19vaccinationareportoftwocases
AT chetchotisakdploenchan varicellazostermeningitisfollowingcovid19vaccinationareportoftwocases

Ejemplares similares